APP and Dravet syndrome: Recent studies in preclinical systems have demonstrated that an extra copy of other genes on Hsa21 can modulate APP biology (Garcia-Cerro et al., 2017; Wiseman et al., 2018, Alic et al., 2020, Tosh et al., 2021) and thus may alter the earliest stages of AD in individuals who have DS.